Asian Spectator


The Times

.

Supreme Court unanimously concludes that anti-abortion groups have no standing to challenge access to mifepristone – but the drug likely faces more court challenges

  • Written by Naomi Cahn, Professor of Law, University of Virginia
Supreme Court unanimously concludes that anti-abortion groups have no standing to challenge access to mifepristone – but the drug likely faces more court challengesActivists on both sides of the abortion battle are gearing up for it to be a major issue in the 2024 election. Pacific Press/LightRocket via Getty Images

On June 13, 2024, the Supreme Court of the United States unanimously decided to uphold access to mifepristone, one of two pills used in medication abortion. Mifepristone has long been used safely...

Magazine

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

Why Early Protection of Intellectual Assets is Critical

For many businesses, intellectual assets are among the most valuable things they own, yet they're often the last to receive formal legal protection. A brand name or a proprietary process can represe...

hacklink hack forum hacklink film izle hacklink z-librarytelegram下载jojobet girişgrandpashabetgrandpashabet twiter xbaymavitelegram webbetasus girişcasibomdeneme bonusu veren sitelermadridbetdeneme bonusubetwoonagen bolajojobetholiganbetholiganbetjojobetjojobetjojobet